Phost'in Therapeutics
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
79 1,525Activities
Technologies
Entity types
Location
104 Rue de La Galera, 34090 Montpellier, France
Montpellier
France
Employees
Scale: 2-10
Estimated: 14
Engaged corporates
11
6 7Added in Motherbase
3 years, 2 months ago
biotech Value proposition
Unmask Cancer, Elicit Immune Response
Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases.
A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response.
Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors.
Glyco Immuno OncologyOriginal language
Unmask Cancer, Elicit Immune Response
Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases.
A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response.
Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors.
Phost'in Therapeutics: unmask cancer, elicit immune response
Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases
https://www.phostin.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 18 Jan 2024 | | |
 | SATT AxLR | Other 11 Oct 2023 | | |
 Entreprendre à Montpellier Startup accelerator & VC, Government Administration | Entreprendre à Montpellier Startup accelerator & VC, Government Administration | Other 7 Jul 2023 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 5 Oct 2024 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 20 Sep 2022 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 5 Oct 2024 | | |
 Business France National and local authorities, Government Administration | Business France National and local authorities, Government Administration | Other 31 May 2022 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 20 Oct 2023 | | |
 Euronext Finance, Financial Services | Euronext Finance, Financial Services | Other 28 Feb 2022 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 29 Aug 2023 | | |